Indications and Purposes
| 1 Indications And Usage Alecensa Is Indicated For The Treatment Of Patients With Anaplastic Lymphoma Kinase (Alk)-Positive Metastatic Non-Small Cell Lung Cancer (Nsclc) As Detected By An Fda-Approved Test. Alecensa Is A Kinase Inhibitor Indicated For The Treatment Of Patients With Anaplastic Lymphoma Kinase (Alk)-Positive Metastatic Non-Small Cell Lung Cancer (Nsclc) As Detected By An Fda-Approved Test. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Alectinib Hydrochloride |